201 related articles for article (PubMed ID: 2356855)
21. Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2.
Bodmer S; Strommer K; Frei K; Siepl C; de Tribolet N; Heid I; Fontana A
J Immunol; 1989 Nov; 143(10):3222-9. PubMed ID: 2809198
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical expression of angiogenic cytokines and their receptors in reactive benign lymph nodes and non-Hodgkin lymphoma.
Ho CL; Sheu LF; Li CY
Ann Diagn Pathol; 2003 Feb; 7(1):1-8. PubMed ID: 12616467
[TBL] [Abstract][Full Text] [Related]
23. Histological study of Hodgkin disease (HD), an immunohistochemical identification of the cells surrounding Sternberg-Reed cells.
Mihailovici MS; Scripcaru D; Butcovan D; Teleman S
Rev Med Chir Soc Med Nat Iasi; 1997; 101(1-2):135-43. PubMed ID: 10756742
[TBL] [Abstract][Full Text] [Related]
24. Hodgkin's disease in the Philippines.
Paulino AF; Paulino-Cabrera E; Weiss LM; Medeiros LJ
Mod Pathol; 1996 Feb; 9(2):115-9. PubMed ID: 8657716
[TBL] [Abstract][Full Text] [Related]
25. BAX expression in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: correlation with clinical outcome.
Rassidakis GZ; Medeiros LJ; McDonnell TJ; Viviani S; Bonfante V; Nadali G; Vassilakopoulos TP; Giardini R; Chilosi M; Kittas C; Gianni AM; Bonadonna G; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH
Clin Cancer Res; 2002 Feb; 8(2):488-93. PubMed ID: 11839668
[TBL] [Abstract][Full Text] [Related]
26. The nature of the lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin's disease.
Poppema S
Am J Pathol; 1989 Aug; 135(2):351-7. PubMed ID: 2675617
[TBL] [Abstract][Full Text] [Related]
27. Vascular activation in the histopathogenesis of Hodgkin's disease: potential role of endothelial tissue factor in intravascular thrombosis and necrosis.
Ruco LP; Pittiglio M; Dejana E; Baroni CD
J Pathol; 1993 Oct; 171(2):131-6. PubMed ID: 7506770
[TBL] [Abstract][Full Text] [Related]
28. Expression of interleukin-2R alpha and interleukin-2R beta in Hodgkin's disease.
Tesch H; Günther A; Abts H; Jücker M; Klein S; Krueger GR; Diehl V
Am J Pathol; 1993 Jun; 142(6):1714-20. PubMed ID: 8506943
[TBL] [Abstract][Full Text] [Related]
29. Further studies of the role of transforming growth factor-beta in human B cell function.
Kehrl JH; Taylor AS; Delsing GA; Roberts AB; Sporn MB; Fauci AS
J Immunol; 1989 Sep; 143(6):1868-74. PubMed ID: 2550546
[TBL] [Abstract][Full Text] [Related]
30. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma.
Timens W; Visser L; Poppema S
Lab Invest; 1986 Apr; 54(4):457-61. PubMed ID: 3083157
[TBL] [Abstract][Full Text] [Related]
31. [High prevalence of the Epstein-Barr virus in a Mexican population with Hodgkin's disease].
Quintanilla-Martínez L; Gamboa-Domínguez A; Gámez-Ledesma I; Orozco-Estévez H; Angeles-Angeles A
Rev Invest Clin; 1994; 46(5):355-62. PubMed ID: 7839015
[TBL] [Abstract][Full Text] [Related]
32. Low p53 and high bcl-2 expression in Reed-Sternberg cells predicts poor clinical outcome for Hodgkin's disease: involvement of apoptosis resistance?
Brink AA; Oudejans JJ; van den Brule AJ; Kluin PM; Horstman A; Ossenkoppele GJ; van Heerde P; Jiwa M; Meijer CJ
Mod Pathol; 1998 Apr; 11(4):376-83. PubMed ID: 9578089
[TBL] [Abstract][Full Text] [Related]
33. Abundance of heat shock proteins (hsp89, hsp60, and hsp27) in malignant cells of Hodgkin's disease.
Hsu PL; Hsu SM
Cancer Res; 1998 Dec; 58(23):5507-13. PubMed ID: 9850087
[TBL] [Abstract][Full Text] [Related]
34. Abundant expression of transforming growth factor-beta 1 and -beta 2 by Hodgkin's Reed-Sternberg cells and by reactive T lymphocytes in Hodgkin's disease.
Hsu SM; Lin J; Xie SS; Hsu PL; Rich S
Hum Pathol; 1993 Mar; 24(3):249-55. PubMed ID: 7681031
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease.
Hsu SM; Xie SS; Hsu PL; Waldron JA
Am J Pathol; 1992 Jul; 141(1):129-38. PubMed ID: 1632458
[TBL] [Abstract][Full Text] [Related]
36. Expression of cell adhesion molecules associated with germinal center in Hodgkin's disease: an immunohistochemical study. The germinal center related complex and histologic subtypes.
Ree HJ; Khan AA; Qureshi MN; Teplitz C
Cancer; 1994 Feb; 73(4):1257-63. PubMed ID: 7906194
[TBL] [Abstract][Full Text] [Related]
37. Basic fibroblast growth factor and fibrosis in Hodgkin's disease.
Ohshima K; Sugihara M; Suzumiya J; Haraoka S; Kanda M; Shimazaki K; Katoh K; Kumagawa M; Kikuchi M
Pathol Res Pract; 1999; 195(3):149-55. PubMed ID: 10220794
[TBL] [Abstract][Full Text] [Related]
38. Reed-Sternberg cells of classical Hodgkin's disease react with the plasma cell-specific monoclonal antibody B-B4 and express human syndecan-1.
Carbone A; Gloghini A; Gattei V; Degan M; Improta S; Aldinucci D; Canzonieri V; Perin T; Volpe R; Gaidano G; Zagonel V; Pinto A
Blood; 1997 May; 89(10):3787-94. PubMed ID: 9160685
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor beta 1 messenger RNA in Reed-Sternberg cells in nodular sclerosing Hodgkin's disease.
Newcom SR; Gu L
J Clin Pathol; 1995 Feb; 48(2):160-3. PubMed ID: 7745117
[TBL] [Abstract][Full Text] [Related]
40. L-428 nodular sclerosing Hodgkin's cell secretes a unique transforming growth factor-beta active at physiologic pH.
Newcom SR; Kadin ME; Ansari AA; Diehl V
J Clin Invest; 1988 Dec; 82(6):1915-21. PubMed ID: 2904450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
